Huntington's Disease Pipeline and Market Analysis, H1 2015

Submitted by: Submitted by

Views: 10

Words: 573

Pages: 3

Category: Business and Industry

Date Submitted: 08/06/2015 12:59 AM

Report This Essay

This report provides comprehensive information on the therapeutic development for Huntington's Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Huntington's Disease and special features on late-stage and discontinued projects.

Inquire more about this report at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=400810 . (This is a premium report price at US$2000 for a single user PDF license)

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information.

Complete Report is available at http://www.rnrmarketresearch.com/huntingtons-disease-pipeline-review-h1-2015-market-report.html .

Scope of the Report:

• The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities

• The report reviews key players involved in the therapeutics...